Article
Frequency of CYP2B6 Alleles in Major Iranian Ethnicities, Affecting Response to Efavirenz.
Genetics research - 1 Jan 2022
Mardi Parham, Tavakoli-Far Bahareh, Sheibani Nia Samira, Jazayeri Roshanak, Houshmand Massoud
Abstract excerpt
Introduction: Efavirenz is an antihuman immunodeficiency virus (HIV) drug metabolized by cytochrome P450 2B6 (CYP2B6) enzyme. Cytochrome P450 2B6 is an enzyme that in humans is encoded by the CYP2B6 gene. Polymorphisms of this gene play a crucial role in the metabolism of drugs such as Efavirenz. This study aims to evaluate the frequency of three clinically significant CYP2B6 polymorphisms (CYP2B6 ∗ 6 (516G > T),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
